Clinical Trial Update: Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer Dyspepsia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a 14-day Modified Bismuth Quadruple Therapy for Helicobacter pylori eradication in areas with high resistance; study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• Bismuth subsalicylate (bismuth subsalicylate)
• METRONIDAZOLE (Metronidazole)
• Omeprazole (Omeprazole)
• tetracycline (tetracycline)

Snippet

Sponsor: Athens Medical Center | Conditions: Helicobacter Pylori Gastritis, Helicobacter Eradication | Phase 4 | Status: NOT_YET_RECRUITING